Measles-containing-vaccine first-dose (MCV1) immunization coverage in Algeria
Algeria: Measles-containing-vaccine first-dose (MCV1) immunization coverage was 96.0% in 2025. ▲ Rising
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Algeria, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for measles-containing-vaccine first-dose (mcv1) immunization coverage in Algeria is 96.0%, measured in 2025.
That represents a change of up 2.1% on the previous year and up 1.1% over ten years.
Over the whole period, measles-containing-vaccine first-dose (mcv1) immunization coverage in Algeria peaked at 99.0% in 2023 and was at its lowest, 79.0%, in 2021.
That places Algeria 42nd out of 194 countries with data for 2025, putting it in the top quarter.
The long-run direction has been consistently rising across the 26 years of available data.
Measles-containing-vaccine first-dose (MCV1) immunization coverage in Algeria, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 80.0% | — |
| 2001 | 83.0% | +3.8% |
| 2002 | 81.0% | -2.4% |
| 2003 | 84.0% | +3.7% |
| 2004 | 81.0% | -3.6% |
| 2005 | 83.0% | +2.5% |
| 2006 | 91.0% | +9.6% |
| 2007 | 92.0% | +1.1% |
| 2008 | 88.0% | -4.3% |
| 2009 | 92.0% | +4.5% |
| 2010 | 95.0% | +3.3% |
| 2011 | 95.0% | +0.0% |
| 2012 | 95.0% | +0.0% |
| 2013 | 95.0% | +0.0% |
| 2014 | 95.0% | +0.0% |
| 2015 | 95.0% | +0.0% |
| 2016 | 94.0% | -1.1% |
| 2017 | 88.0% | -6.4% |
| 2018 | 80.0% | -9.1% |
| 2019 | 80.0% | +0.0% |
| 2020 | 80.0% | +0.0% |
| 2021 | 79.0% | -1.2% |
| 2022 | 79.0% | +0.0% |
| 2023 | 99.0% | +25.3% |
| 2024 | 94.0% | -5.1% |
| 2025 | 96.0% | +2.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 85.5% | 80.0% | 92.0% | 10 |
| 2010s | 91.2% | 80.0% | 95.0% | 10 |
| 2020s | 87.8% | 79.0% | 99.0% | 6 |
Countries ranked near Algeria
More health data for Algeria
- Un projection of annual infant deaths, annual growth rate -1.82 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5437 % change on previous year (2090)
- Heat deaths vs projected death rates 943.1 (2090)
- Un projection of annual infant deaths 1,455 (2100)
- Population ages 0-14, female, annual growth rate -0.0122 % change on previous year (2025)
- Population ages 0-14, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, female, per capita 0.1466 units per person (2025)
- Population ages 0-14, male, annual growth rate -0.0305 % change on previous year (2025)
- Population ages 0-14, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 0-14, male, per capita 0.1527 units per person (2025)
Frequently asked questions
- What is measles-containing-vaccine first-dose (mcv1) immunization coverage in Algeria?
- Measles-containing-vaccine first-dose (mcv1) immunization coverage in Algeria was 96.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Algeria?
- The highest recorded value was 99.0% in 2023.
- What is the lowest measles-containing-vaccine first-dose (mcv1) immunization coverage recorded in Algeria?
- The lowest recorded value was 79.0% in 2021.
- How does Algeria rank for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Algeria ranks 42nd out of 194 countries with data for 2025.
- Is measles-containing-vaccine first-dose (mcv1) immunization coverage rising or falling in Algeria?
- Over the last ten years it is up 1.1%. The long-run trend across the full record is rising.
- Where does this Algeria data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).